Gilead has begun testing its COVID-19 coronavirus antiviral remdesivir in the UK, announcing plans to trial the drug in patients in England and Scotland.
At eyeforpharma Daiichi Sankyo’s Manuel Reiberg spoke about why the industry should look to make drugs more affordable in the wake of the COVID-19 pandemic and “leave the next generation a healt
Johnson & Johnson has announced plans to team up with the US government to invest more than $1 billion in a new vaccine against COVID-19, aiming to begin clinical trials by September.<
